#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic myelomonocytic leukaemia Chronic hepatitis B CDKL5 deficiency disorder Ureteric cancer Nephropathy Sickle cell disease Leukocyte adhesion deficiency type I Pulmonary arterial hypertension Acute lymphocytic leukaemia recurrent Peritoneal neoplasm Haematological malignancy Cardiac arrest Hodgkin's disease refractory Mantle cell lymphoma stage II Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Trials in Disease Alveolar rhabdomyosarcoma – Treatment Castleman’s disease – Trials in Disease Waldenstrom’s macroglobulinaemia – Treatment Gaucher’s disease type III – Trials in Disease Urea cycle disorder – Trials in Disease Castleman’s disease – Diagnostics Pulmonary fibrosis – Trials in Disease Primary biliary cholangitis – Diagnostics Systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ketotifen Hydrogen Fumarate Ranibizumab Sodium Ascorbate Carcik-Cd19 Cells Ambrisentan Specific Nucleic Acid Sna-Xfsc Ethinylestradiol Gskvx000000008866 Ag-946 Phosphate Ofloxacin Hydrochloride 20-HYDROXYECDYSONE Benfotiamine Specific Nucleic Acid Sna-Her2 Etripamil AGA2118 Lonvoguran Certolizumab Pegol Tobevibart Cariprazine Hydrochloride UDONITRECTAG More therapies…

    Learn about Your Condition

    Tumour of ampulla of Vater Malignant melanoma stage II Febrile neutropenia Haemofiltration Pyoderma gangrenosum Demyelination Limb reduction defect Metastatic malignant melanoma Urea cycle disorder Schizophrenia Pulmonary venous thrombosis Spermatocele Dent's disease Vestibular disorder Psoriatic arthropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the safety and effectiveness of omalizumab in adults with episodic migraine

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Omalizumab
    Norway

  • Personalizing treatment for patients with HR-positive, HER2-negative metastatic breast cancer using fulvestrant, elacestrant, capivasertib, capecitabine, or a drug combination.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Elacestrant
    • Capivasertib
    • Fulvestrant
    Italy

  • A feasibility study of dapagliflozin for elderly patients hospitalized with chronic heart failure.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    • Cardiac failure chronic
    Investigated Drugs:
    • Dapagliflozin Propanediol Monohydrate
    France

  • Effect of ramipril, acetylsalicylic acid, and atorvastatin calcium trihydrate plus nurse education on treatment adherence in patients with acute coronary syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    Investigated Drugs:
    • Atorvastatin Calcium Trihydrate
    • Atorvastatin
    • Acetylsalicylic Acid
    Spain

  • A study evaluating the use of semaglutide for treating obstructive sleep apnea in older adults who are overweight or have obesity

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Investigated Drugs:
    • Semaglutide
    Spain

  • A study of rilvegostomig and ramucirumab in patients with advanced or metastatic non-small cell lung cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ramucirumab
    • Rilvegostomig
    Belgium France Germany Italy The Netherlands Poland +1
Previous Page
1 … 729 730 731 732 733 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!